Engineered Nanozymes with Asymmetric Mn─O─Ce Sites for Intratumorally Leveraged Multimode Therapy
Advanced Materials · 2025-07 · 37 (30)
DOI: 10.1002/adma.202419673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 09.05.2025. Verfasst von Jin Ye und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Forest Plant Ecology, Ministry of Education, College of Chemistry, Chemical Engineering and Resource Utilization, Northeast Forestr…. Hauptthemen laut MEDLINE: Manganese, Cerium, Antineoplastic Agents. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 121 Literaturangaben. Gefördert von: National Key Research and Development Program of China, 111 Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Due to the enhanced flexibility of catalytic sites and synergistic effects between dual‐atom active centers, dual‐atom nanozymes stand out in the tumor catalytic therapy. However, precisely regulating the d‐band centers of diatomic sites to break the linear‐scaling relationship between intermediates remains a challenge. Herein, the hydrothermally mass‐produced oxygen vacancies‐engineered bimetallic silicate bio‐nanoplatform with highly asymmetric O‐bridged cerium─manganese (Ce─Mn) diatomic catalytic centers (CeMn‐V DAs/EGCG@HA) is meticulously constructed by loading epigallocatechin‐3‐gallate (EGCG) and modifying with hyaluronic acid (HA) for multimodal synergistic cancer therapy. Theoretical calculations reveal that the introduction of Ce sites serves as secondary catalytic centers and upshifts d‐band center of the Mn sites, thereby optimizing the adsorption/desorption of oxygen intermediates. The asymmetric Mn─O─Ce moiety facilitates electron transport within CeMn‐V DAs, significantly enhancing peroxidase‐like activities ( K m = 27.7 mM and V max = 3.21×10 ─7 M s ─1 ). Upon 650 nm laser irradiation, CeMn‐V DAs/EGCG inhibits heat shock protein expression, enabling mild‐photothermal ( η = 36.1%) therapy, which can productively inhibit tumor growth in vivo, with an inhibition rate of up to 96.2%. Due to the ligand‐field effect of EGCG‐Mn/Ce complexes, high‐valent metal ions are effectively reduced, sustaining an intrinsic self‐driven cocatalytic cycle reaction. Overall, the construction of highly asymmetric bridged diatomic nanozymes will further promote the deep integration of nanotechnology and biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Forest Plant Ecology, Ministry of Education, College of Chemistry, Chemical Engineering and Resource Utilization, Northeast Forestry University, Harbin, 150001, P. R. China.
- Heilongjiang Provincial Key Laboratory of Ecological Utilization of Forestry-Based Active Substances, Northeast Forestry University, Harbin, 150040, P. R. China.
- Department of Physics, Zhejiang Sci-Tech University, Hangzhou, 310018, P. R. China.
- School of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou, 310018, P. R. China.
- Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Material Sciences and Chemical Engineering, Harbin Engineering University, Harbin, 150001, P. R. China.
ORCID-Profile: Jiating Xu
Förderung
- National Key Research and Development Program of China
- 111 Project
- National Natural Science Foundation of China
- Heilongjiang Touyan Innovation Team Program
- Higher Education Discipline Innovation Project
Zitieren
APA
Ye, J., Li, C., Xu, J., Liu, S., Qu, J., Wang, Q., Cao, J., Zhao, Y., Li, C., & Yang, P. (2025). Engineered Nanozymes with Asymmetric Mn─O─Ce Sites for Intratumorally Leveraged Multimode Therapy. Advanced Materials, 37(30). https://doi.org/10.1002/adma.202419673
Vancouver
Ye J, Li C, Xu J, Liu S, Qu J, Wang Q, et al. Engineered Nanozymes with Asymmetric Mn─O─Ce Sites for Intratumorally Leveraged Multimode Therapy. Advanced Materials. 2025;37(30). doi:10.1002/adma.202419673
BibTeX
@article{Ye2025,
author = {Ye, Jin and Li, Chunsheng and Xu, Jiating and Liu, Shuang and Qu, Jiawei and Wang, Qiang and Cao, Jun and Zhao, Yanying and Li, Chaorong and Yang, Piaoping},
title = {Engineered Nanozymes with Asymmetric Mn─O─Ce Sites for Intratumorally Leveraged Multimode Therapy},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {30},
doi = {10.1002/adma.202419673}
}
EUVIMED